Evidence map›Paper›PMID 42237306›Full record

ArticleBMC biotechnology2026

Modified langendorff-free method for isolating cardiomyocytes and non-cardiomyocytes from adult mice.

Runhua Li, Jia Shen, Shuang Li, Yingchao Shi, Wenting Zhao, Chenqiu Wang, Lu Chen, Jiamian Chen, Xiaolei Cheng, Junyue Xing and 7 more

Abstract read
In one paragraph

Article in BMC biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Runhua Li *Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450014, China.
Jia Shen *Zhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Shuang Li *Zhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Yingchao ShiZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Wenting ZhaoThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Chenqiu WangZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Lu ChenZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Jiamian ChenDepartment of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450014, China.
Xiaolei ChengZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Junyue XingZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Zhen LiZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Tongguang ShiHenan Medical University, Xinxiang, Henan, 453003, China.
Chuanyu GaoZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China.
Hao TangZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China. tangpku_zzuhao@zzu.edu.cn.
Liguo JianDepartment of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450014, China. sahjlg@zzu.edu.cn.
Dongdong JianZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China. jdd1102@bjmu.edu.cn.
Datun QiZhengzhou Key Laboratory of Cardiovascular Aging, Laboratory of Cardiovascular Regenerative Medicine, National Health Commission Key, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451450, China. qimedicine@zzu.edu.cn.

Funding

Henan Cardiovascular Disease Center 2023-FZX23,2023-FZX07National Natural Science Foundation of China 82570333Natural Science Foundation of Henan Province 24230421281Zhejiang Provincial Medical and Health Science and Technology Program Project 2023RC016
6 · The paper itself

Abstract

backgroundAdult murine cardiomyocytes serve as a pivotal model for cardiovascular research. High-quality isolation is essential for studying disease mechanisms and drug screening. Current methods, however, are limited by reliance on specialized equipment and inconsistent efficiency, necessitating a more convenient and reliable protocol. METHODS AND

resultsWe developed an optimized, Langendorff-free method for isolating cardiomyocytes and cardiac fibroblasts from adult mice. Following anesthesia, an enzymatic digestion solution was infused directly via the aortic root, utilizing the coronary circulation to achieve efficient tissue dissociation. This approach yielded adult mouse cardiomyocytes with high viability, intact morphology, and suitability for long-term culture, comparable to the standard Langendorff technique. Functionally, the isolated cardiomyocytes retained robust responsiveness to pathological stimuli, including hypoxia and adrenergic agonists (isoprenaline, norepinephrine, phenylephrine), demonstrated by characteristic alterations in contractile function, relaxation kinetics, and calcium handling. Furthermore, cardiac fibroblasts co-isolated using this protocol could be successfully activated by TGF-β, showing significant upregulation of myofibroblast markers (e.g., α-smooth muscle actin) and pro-fibrotic signaling pathways.

conclusionThis study establishes a novel, efficient, and accessible method for the simultaneous isolation of functional cardiomyocytes and cardiac fibroblasts from adult mice. The protocol overcomes key limitations of existing techniques and provides a reliable platform for in vitro mechanistic studies and drug discovery in cardiovascular disease.

Indexed as

Cell SeparationFibroblastsMyocytes, CardiacAnimalsCells, CulturedMaleMiceMice, Inbred C57BLCardiac fibroblastsCardiomyocytesLangendorff-freeMouse modelsSingle-cell isolation

Identifiers

PMID42237306
PMCPMC13450364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.